Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Judit Kállai"'
Autor:
Tibor G. Szanto, Adam Feher, Eva Korpos, Adrienn Gyöngyösi, Judit Kállai, Beáta Mészáros, Krisztian Ovari, Árpád Lányi, Gyorgy Panyi, Zoltan Varga
Publikováno v:
Pharmaceuticals, Vol 16, Iss 5, p 656 (2023)
5-chloro-2-guanidinobenzimidazole (ClGBI), a small-molecule guanidine derivative, is a known effective inhibitor of the voltage-gated proton (H+) channel (HV1, Kd ≈ 26 μM) and is widely used both in ion channel research and functional biological a
Externí odkaz:
https://doaj.org/article/e7f674d9917e473ca32a50d14f6f19ab
Autor:
Réka Gindele, Krisztina Pénzes-Daku, Gábor Balogh, Judit Kállai, Réka Bogáti, Bálint Bécsi, Ferenc Erdődi, Éva Katona, Zsuzsanna Bereczky
Publikováno v:
Biomolecules, Vol 11, Iss 4, p 544 (2021)
Antithrombin (AT) is a serine protease inhibitor, its activity is highly accelerated by heparin. Mutations at the heparin-binding region lead to functional defect, type II heparin-binding site (IIHBS) AT deficiency. The aim of this study was to inves
Externí odkaz:
https://doaj.org/article/f502af7ffe504ea482bb9d1edd87e030
Autor:
Réka Gindele, Adrienne Kerényi, Judit Kállai, György Pfliegler, Ágota Schlammadinger, István Szegedi, Tamás Major, Zsuzsanna Szabó, Zsuzsa Bagoly, Csongor Kiss, János Kappelmayer, Zsuzsanna Bereczky
Publikováno v:
Life, Vol 11, Iss 3, p 202 (2021)
Diagnosis of rare bleeding disorders is challenging and there are several differential diagnostics issues. Next-generation sequencing (NGS) is a useful tool to overcome these problems. The aim of this study was to demonstrate the usefulness of molecu
Externí odkaz:
https://doaj.org/article/701e79842d7344f49c5b1ac8c1499b3c
Autor:
Halmos, Krisztián Szegedi, Zsuzsanna Szabó, Judit Kállai, József Király, Erzsébet Szabó, Zsuzsanna Bereczky, Éva Juhász, Balázs Dezső, Csaba Szász, Barbara Zsebik, Tibor Flaskó, Gábor
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 13; Pages: 4538
The genetic profiling of renal tumors has revealed genomic regions commonly affected by structural changes and a general genetic heterogeneity. The VHL, PTEN, and BAP1 genes are often mutated in renal tumors. The frequency and clinical relevance of t
The Voltage-Gated Hv1 H+ Channel Is Expressed in Tumor-Infiltrating Myeloid-Derived Suppressor Cells
Autor:
Marco Cozzolino, Adrienn Gyöngyösi, Eva Korpos, Peter Gogolak, Muhammad Umair Naseem, Judit Kállai, Arpad Lanyi, Gyorgy Panyi
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 7; Pages: 6216
Myeloid-derived suppressor cells (MDSCs) are key determinants of the immunosuppressive microenvironment in tumors. As ion channels play key roles in the physiology/pathophysiology of immune cells, we aimed at studying the ion channel repertoire in tu
Autor:
Melinda Erdős, Kristina Mironska, Lidia Kareva, Katarina Stavric, Arijeta Hasani, Árpád Lányi, Judit Kállai, László Maródi
Publikováno v:
Pediatric Allergy and Immunology. 33
Autor:
Judit Kállai, Satoshi Okada, Zoltán Nyul, Miyuki Tsumura, László Maródi, György Balázs, Melinda Erdős, Arpad Lanyi
Publikováno v:
Clinical and Experimental Immunology
Signal transducer and activator of transcription 3 (STAT‐3) gain‐of‐function (GOF) syndrome is an early‐onset monogenic inborn error of immunity characterized by multi‐organ autoimmune disorders, growth failure and lymphoproliferation. We d
Autor:
Judit Kállai, Zsuzsanna Bereczky, Éva Katona, Tünde Miklós, Réka Bogáti, Zoltán András Mezei, Barbara Barath, László Muszbek
Publikováno v:
Thrombosis research. 203
Introduction Alpha2-plasmin inhibitor (α2-PI) has a heterogeneous composition in the plasma. Both N- and C-terminal cleavages occur that modify the function of the molecule. C-terminal cleavage converts the plasminogen-binding form (PB-α2-PI) to a
Autor:
Éva Ajzner, László Muszbek, Zsuzsa Bagoly, Tünde Miklós, Zsuzsanna Bereczky, Éva Molnár, Judit Kállai, Zoltán András Mezei, Éva Katona, Bettina Kovács
Publikováno v:
Thrombosis Research. 148:101-106
Background The regulation of plasma factor XIII (FXIII) levels in healthy individuals has been only partially explored. The identification of major non-genetic and genetic regulatory factors might provide important information on the contribution of
Autor:
Zoltán András Mezei, Judit Kállai, Zsuzsanna Bereczky, Bettina Kovács, Éva Ajzner, Éva Katona, László Muszbek, Tünde Miklós, Éva Molnár, Laura Somodi
Publikováno v:
Thrombosis research. 158
Background The association of plasma factor XIII (FXIII) level with venous thromboembolism (VTE) is still controversial and the effect of sex and FXIII B subunit (FXIII-B) polymorphisms in this respect have not been explored. Objectives 1/ To determi